Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jun;43(7):929-936.
doi: 10.1002/pd.6390. Epub 2023 Jun 11.

The clinical impact of the first-trimester nuchal translucency between the 95th-99th percentiles

Affiliations

The clinical impact of the first-trimester nuchal translucency between the 95th-99th percentiles

Ilaria Fantasia et al. Prenat Diagn. 2023 Jun.

Abstract

Objectives: To evaluate the clinical significance of nuchal translucency (NT) between the 95th-99th percentile in terms of typical and atypical chromosomal abnormalities (ACAs), associated fetal congenital defects and postnatal outcome.

Methods: A retrospective cohort study of fetuses with NT between the 95th-99th percentile. Data regarding the rate of associated fetal defects, genetic abnormalities and postnatal outcome were collected.

Results: A total of 306 cases of fetuses with an NT between the 95th-99th percentiles were included. The overall rate of genetic abnormalities was 12.1% (37/306). Chromosomal abnormalities were found in 10.1% (31/306) of cases and 2% were ACA (6/306). Within this group, two were pathogenic Copy Number Variants (CNVs) and four were single gene disorders. The overall rate of fetal congenital defects was 13.7% (42/306). All ACAs were found in fetuses with congenital defects. Postnatally, a new diagnosis of a single gene disorder was made in 0.85% of cases (2/236).

Conclusions: The presence of an NT between the 95th-99th percentiles carries a 10-fold increased risk of fetal defects, representing an indication for referral for a detailed fetal anatomy evaluation. The risk of ACA is mainly related to the presence of fetal defects, irrespective of the combined test risk.

PubMed Disclaimer

References

REFERENCES

    1. Salomon LJ , Alfirevic Z , Bilardo CM , et al. ISUOG practice guidelines: performance of first-trimester fetal ultrasound scan. Ultrasound Obstet Gynecol. 2013;41:102-113.
    1. Nicolaides KH , Brizot ML , Snijders RJ . Fetal nuchal translucency: ultrasound screening for fetal trisomy in the first trimester of pregnancy. Br J Obstet Gynaecol. 1994;101(9):782-786. https://doi.org/10.1111/j.1471-0528.1994.tb11946.x
    1. Souka AP , Von Kaisenberg CS , Hyett JA , Sonek JD , Nicolaides KH . Increased nuchal translucency with normal karyotype. Am J Obstet Gynecol. 2005;192(4):1005-1021. https://doi.org/10.1016/j.ajog.2004.12.093
    1. Sotiriadis A , Papoulidis I , Siomou E , et al. Non-invasive prenatal screening versus prenatal diagnosis by array comparative genomic hybridization: a comparative retrospective study. Prenat Diagn. 2017;37(6):583-359. https://doi.org/10.1002/pd.5051
    1. Bilardo CM , Timmerman E , Pajkrt E , van Maarle M . Increased nuchal translucency in euploid fetuses-what should we be telling the parents? Prenat Diagn. 2010;30(2):93-102. https://doi.org/10.1002/pd.2396

LinkOut - more resources